Both in Biotechnology
X4 Pharmaceuticals vs Fate Therapeutics
Over the past year XFOR returned −13.4% and FATE returned +138.0%; their daily moves had a correlation of 0.22.
XFOR −13.4% FATE +138.0%Growth of $1, one year, split-adjusted
| Metric | XFOR | FATE |
|---|---|---|
| Price | $2.90 | $2.38 |
| Market cap | $287.5M | $285.2M |
| Today | −3.81% | 0.00% |
| 1 month | −28.2% | −2.1% |
| 6 months | −27.3% | +110.6% |
| Year to date | −27.5% | +142.2% |
| 1 year | −16.2% | +138.0% |
| Revenue growth (YoY) | +346.3% | +9.2% |
| Gross margin | 81.6% | 100.0% |
| Net margin | −183.5% | −1448.6% |
| P/E (TTM) | — | — |
| Price / sales | 18.1× | 43.9× |
| Net cash | $131.2M | $153.8M |
| Dividend yield | — | — |
| Volatility (60d) | 64.2% | 59.6% |
| Short % of float | 9.6% | 9.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).